Isolation and characterization of novel process-related impurities in empagliflozin

Determination of empagliflozin in the presence of its organic impurities and identification of two degradation products using UHPLC-QTOF/MS

(2020) Joanna Wittckind Manoel et al.   MICROCHEMICAL JOURNAL

Empagliflozin: A Review in Type 2 Diabetes

(2018) James E. Frampton   DRUGS

Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

(2015) John R. White   ANNALS OF PHARMACOTHERAPY

Synthesis of empagliflozin, a novel and selective sodium-glucose co-transporter-2 inhibitor, labeled with carbon-14 and carbon-13

(2014) Matt Hrapchak et al.   JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Efficient Synthesis of Empagliflozin, an Inhibitor of SGLT-2, Utilizing an AlCl3-Promoted Silane Reduction of a β-Glycopyranoside

(2014) Xiao-jun Wang et al.   ORGANIC LETTERS

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors

(2011) R. Grempler et al.   DIABETES OBESITY & METABOLISM